Switch to
More onapp

Lotus Eye Hospital and Institute Ltd

LOTUSEYE
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹143 cr, stock is ranked 2,008
High RiskStock is 3.57x as volatile as Nifty
69.000.15 (-0.22%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹143 cr, stock is ranked 2,008
High RiskStock is 3.57x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
48.10
PB RatioPB Ratio
2.63
Dividend YieldDiv. Yield
0.72%
Sector PESector PE
33.80
Sector PBSector PB
4.14
Sector Div YldSctr Div Yld
0.93%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lotus Eye Hospital and Institute Limited is engaged in the provision of healthcare services. The Company is engaged in the field of ophthalmology (eye) and its related operation.

Financial TrendFinancial statements 

201920202021202239.1141.4833.2039.800.711.051.572.99
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Updates 
Announced OnJan 14, 2023

Lotus Eye Hospital and Institute Limited has informed the Exchange regarding 'Reconciliation of Share Capital Audit for the quarter ended 31.12.2022 as per Regulation 76 of the SEBI (DP) Regulation,2018 '. | Download

Lotus Eye Hospital and Institute Limited has informed the Exchange regarding 'Reconciliation of Share Capital Audit for the quarter ended 31.12.2022 as per Regulation 76 of the SEBI (DP) Regulation,2018 '. | Download

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnJan 7, 2023

Lotus Eye Hospital and Institute Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Lotus Eye Hospital and Institute Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Cash Dividend 
Ex. DateSep 8, 2022

Final • Div/Share: ₹ 0.5

See all events